Moelis & Co. Class A Actuals & Estimates (NYSE:MC)
This article provides an overview of Moelis & Company (NYSE: MC) stock, including its current price, performance, and analyst forecasts. It details financial actuals and estimates, revenue, net income, dividends, and other key financial metrics, alongside information on market capitalization and upcoming earnings reports.
Moelis & Co (MC) insider sells 4,850 Class A shares at $69.30
Moelis & Co's General Counsel and Secretary, Osamu R. Watanabe, sold 4,850 Class A common stock shares at $69.30 each on August 4, 2026. This transaction was not part of a Rule 10b5-1 trading plan. Following the sale, Watanabe directly holds 131 shares, in addition to unvested equity and shares issuable from Group Units.
Don't Buy Moelis & Company (NYSE:MC) For Its Next Dividend Without Doing These Checks
Moelis & Company (NYSE:MC) is set to trade ex-dividend soon, with an upcoming dividend of US$0.65 per share. The article advises investors to assess the sustainability of the dividend, noting the company paid out 84% of its earnings last year and has shown flat earnings per share growth over the past five years. Due to limited earnings growth and a high payout ratio, the article suggests Moelis might not be an attractive dividend stock.
Weekly Recap: Higher fees, AI and zero debt and Shares $67.78, 7–8% upside
Moelis & Co. (MC) is experiencing revenue growth driven by higher per-deal fees, AI-related work, sponsor monetizations, and liability management. The company is investing in staff, offices, and technology while maintaining strong liquidity and zero debt. Shares of Moelis & Co. Class A are trading around $67.78, with analysts targeting approximately $71.50, suggesting a potential upside of 7-8%.
AstraZeneca Merger Talks Shine A Light On Healthcare Deal Advisors
The potential US$400 billion merger talks between AstraZeneca and Bristol Myers Squibb have brought attention to the healthcare deal advisory sector. This article examines how this development could affect M&A activity and highlights three stocks—Huron Consulting Group (HURN), Gateley (Holdings) (GTLY), and Moelis (MC)—that appear well-positioned to benefit from increased deal-making in the pharmaceutical industry. It provides an overview of each company, their operations, market capitalization, and specific reasons why they are relevant to this theme, alongside their respective opportunities and risks.
Moelis (MC) Stock Draws Focus As Record Margins Meet Valuation Gap
Moelis & Co. (MC) recently reported record Q2 2026 revenue of $409 million and an adjusted pretax margin of 18.6%, leading to a 4.8% stock jump. The company's performance, driven by capital markets and Private Capital Advisory, suggests it's winning high-value work and improving operating leverage, despite lingering concerns about structural fee pressure and margin resilience in a transaction-heavy model. The article delves into both the bull and bear cases for Moelis, highlighting its valuation gap and execution milestones.
Moelis & Company Reports Second Quarter and First Half 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share
Moelis & Company announced strong financial results for the second quarter and first half of 2026, reporting record revenues of $409.4 million and $729.2 million respectively, alongside a 12% and 9% increase from the prior year periods. The firm declared a regular quarterly dividend of $0.65 per share, repurchased 0.3 million shares, and continues to execute its growth strategy by hiring managing directors. These results highlight robust client engagement and momentum in transaction activity.
Moelis & Co (NYSE:MC) Beats Q2 Revenue Estimates While EPS Matches Expectations
Moelis & Company (NYSE:MC) exceeded Q2 revenue estimates, reporting $409.4 million, a 3.1% beat, while adjusted EPS of $0.63 essentially met expectations. The revenue growth was attributed to higher average fees per transaction, and the company also demonstrated a strong balance sheet with significant cash and no funded debt. Moelis declared a regular quarterly dividend of $0.65 per share and repurchased 2.3 million shares, returning a total of $246.4 million to shareholders in the first half of 2026.
Moelis & Company Reports Second Quarter and First Half 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share
Moelis & Company reported strong financial results for Q2 and H1 2026, with revenues increasing by 12% and 9% respectively compared to the prior year. The firm's second-quarter GAAP net income was $55.1 million, or $0.62 per share, and it declared a regular quarterly dividend of $0.65 per share. Growth was attributed to increased average fees per transaction and strategic hiring, while expenses rose due to headcount, travel, and investments.
Are Conflicting Valuations of Moelis (MC) Revealing a Deeper Question About Its Deal-Flow Reliance?
Moelis & Co. Class A (MC) is facing conflicting valuation models: an Excess Returns model suggests upside, while earnings multiples indicate a rich valuation. This disparity highlights the investment bank's reliance on sustained merger and capital-raising activity. The article examines how these conflicting signals reshape Moelis' investment case, considering both the supportive recent share repurchase authorization and the risk of a slowdown in transaction volumes.
Moelis (MC) Rides A Dealmaking Rebound, Is It Still A Bargain?
Moelis (MC) stock has seen a recent rebound, gaining 4.4% after stronger second-quarter investment banking and trading revenues, with M&A and IPO fees reaching 2021 levels. While analysts see it as modestly undervalued, a discounted cash flow model suggests a more significant discount of 26.3% below its estimated future cash flow value. However, risks like higher costs and volatile deal activity remain.
Wasatch discloses 4.4% Moelis & Co stake (NYSE: MC)
Wasatch Advisors has disclosed a 4.4% stake in Moelis & Co (NYSE: MC) through an Amendment No. 1 to a Schedule 13G filing. This beneficial ownership represents 3,246,593 Class A shares, with Wasatch Advisors holding sole voting power over 2,329,525 shares and sole dispositive power over all its holdings. The filing categorizes this as a passive investment, representing less than 5% of the outstanding Class A shares.
Price to earnings forward of Moelis & Co. Class A – BX:17M
This article provides price-to-earnings forward data for Moelis & Co. Class A (BX:17M) on TradingView. It indicates that the market is closed with no trades and lists various financial and community features available on the platform. The content primarily shows navigation elements and structural information rather than a detailed analysis.
Price to earnings forward of Moelis & Co. Class A – MUN:17M
This article displays the "Price to earnings forward" metric for Moelis & Co. Class A (MUN:17M) on the Munich Stock Exchange, as provided by TradingView. The content primarily shows the financial details and market data availability for the company, indicating that no specific value or change is currently available for this metric.
[Form 4] Moelis & Co Insider Trading Activity
Moelis & Co (MC) director Louise Mirrer reported acquiring 1,623 "2026 Annual Restricted Stock Units" as a grant of compensation, valued at $64.68 per share. These RSUs vested on July 1, 2026, and settlement is scheduled within 60 days following July 1, 2028. This transaction was detailed in a Form 4 SEC filing indicating a neutral impact and sentiment.
Form 4 Moelis & Co For: 6 July By Investing.com
This article announces the filing of a Form 4 for Moelis & Co on July 6th. Form 4 filings typically report changes in beneficial ownership of securities by company insiders. The article provides the company's stock symbol (MC) and a current stock performance figure.
Moelis & Co (MC) director Laila Worrell granted 3,400 RSUs as equity compensation
Moelis & Co director Laila Worrell was granted 3,400 restricted stock units (RSUs) as equity compensation on July 1, 2026. These RSUs, comprising 1,777 Elective RSUs and 1,623 Annual RSUs, align her compensation with shareholder interests. The grants are compensation-related and not open-market purchases, with specific vesting and settlement schedules for each type of RSU.
Moelis & Co (MC) director granted 1,900 restricted stock units in 2026 awards
Moelis & Co director Kenneth Shropshire was awarded 1,900 restricted stock units (RSUs) on July 1, 2026, as part of his equity compensation. These awards consist of 1,700 "2026 Annual Restricted Stock Units" and 200 "2026 Elective Restricted Stock Units," each representing one share of Class A common stock. The RSUs were granted based on an average share price of $64.68.
Moelis & Co (MC) director Barker Thorold receives 1,545 RSUs in stock-based award
Moelis & Co director Barker Thorold was granted 1,545 Restricted Stock Units (RSUs) as an equity award. These RSUs, linked to Class A common stock and valued at a reference price of $64.68 per share, vested on July 1, 2026, with settlement expected within 60 days following July 1, 2028. This transaction is considered a routine, non-cash compensation event for a non-employee director and does not involve open-market buying or selling.
Form 4 Moelis & Co For: 6 July By Investing.com
The article reports that a Form 4 filing for Moelis & Co was made on July 6. This is a standard regulatory announcement regarding changes in ownership of company securities by insiders. The article provides no further details about the filing's content.
Moelis & Company Reports First Quarter 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share
Moelis & Company announced record first-quarter 2026 revenues of $319.8 million, a 4% increase year-over-year. The firm reported GAAP diluted EPS of $0.48 and adjusted diluted EPS of $0.50, including a $0.11 per share tax benefit. Moelis also declared a regular quarterly dividend of $0.65 per share and repurchased 1.9 million shares during the quarter, indicating continued strong financial performance and commitment to shareholder returns.
Moelis & Company Reports First Quarter 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share
Moelis & Company reported strong financial results for the first quarter of 2026, with record revenues of $319.8 million, a 4% increase year-over-year. The firm also declared a regular quarterly dividend of $0.65 per share and repurchased 1.9 million shares, totaling $171.4 million in capital returned to shareholders. Strategic growth included adding new Managing Directors and a robust transaction pipeline, positioning the firm for continued performance.
MarketWise Stock And 2 Financial Services Picks For A Tighter Regulatory Era
This article examines three financial services stocks—MarketWise (MKTW), NZX (NZX), and Moelis & Company (MC)—that are positioned to navigate an era of tightening regulatory scrutiny in the financial markets. It highlights their operations, market capitalization, and how they stand to benefit from increased focus on transparency and investor protection, while also pointing out potential risks and factors for investors to consider. The article suggests these companies could be compelling opportunities for long-term investors attentive to regulatory changes.
Moelis & Co. Class A Actuals & Estimates (FWB:17M)
This article provides a comprehensive overview of Moelis & Co. Class A (FWB:17M) stock performance, financial data, and analyst forecasts. It covers current stock price, historical highs and lows, volatility, market capitalization, earnings, revenue, and dividend information. The report also highlights future earnings release dates and provides guidance on how to buy the stock.
Moelis & Co. Class A Actuals & Estimates (BX:17M)
This article provides financial actuals and estimates for Moelis & Co. Class A (BX:17M), including income statement, balance sheet, and cash flow data, alongside analyst price targets and earnings forecasts. It details historical earnings, revenue, net income, dividends, and key financial metrics like EBITDA. The article also provides information on the company's employee count and how to trade its stocks.
Moelis & Co (MC) accounting officer granted multiple dividend-equivalent RSUs
Moelis & Company's Principal Accounting Officer, Nick Riehl, was granted several dividend-equivalent Restricted Stock Units (RSUs) on June 18, 2026. These RSUs, which include various incentive and long-term incentive types, were issued as dividend equivalents on previously granted, unvested RSUs and will vest according to the same schedule as the underlying awards. No open-market purchases or sales were reported in this Form 4 filing, indicating routine equity compensation activity.
[Form 4] Moelis & Co Insider Trading Activity
Moelis & Co director Laila Worrell reported the acquisition of additional restricted stock units (RSUs) as dividend equivalents on existing awards. On June 18, 2026, she acquired 4.6000 2025 Elective RSUs, 16.7600 2025 Annual RSUs, and 20.0800 2024 Annual RSUs, all at a stated price of $0.0000 per unit. These RSUs represent the right to receive one share of Class A Common Stock and will vest concurrently with the underlying RSUs.
Moelis (NYSE: MC) director granted 2024–2025 dividend-equivalent RSUs
Moelis & Co director Louise Mirrer received additional restricted stock units (RSUs) on June 18, 2026, as dividend equivalents tied to prior RSU grants. These included 16.7600 2025 Annual RSUs and 0.3800 and 12.3900 2024 Annual RSUs, all at a stated price of $0.00 per unit, and will vest concurrently with their underlying awards. This transaction is classified as a compensation-related equity accrual rather than an open-market purchase or sale.
Moelis & Co (NYSE: MC) awards dividend-equivalent RSUs to Eric Cantor
Moelis & Co (NYSE: MC) director and Vice Chairman Eric Cantor received several grants of Restricted Stock Units (RSUs) as compensation on June 18, 2026. These awards, including 2024 Long Term Incentive RSUs and various Incentive RSUs, are dividend equivalents tied to his existing unvested RSU grants and will vest concurrently with those underlying awards. The filing indicates no shares were bought or sold in the open market, and the RSUs can be settled in either shares or cash at the company's option.
Form 4 Moelis & Co For: 23 June By Investing.com
This article announces the filing of Form 4 for Moelis & Co on June 23. It provides limited detail beyond this announcement, indicating its primary purpose is to inform stakeholders about the form's submission. The content also lists various financial market data and related articles on Investing.com.
Moelis & Co (MC) director Kenneth Shropshire granted new dividend-equivalent RSUs
Moelis & Co director Kenneth Shropshire was granted additional dividend-equivalent Restricted Stock Units (RSUs) on June 18, 2026. These RSUs, totaling 0.52 2025 Elective RSUs, 17.55 2025 Annual RSUs, and 21.03 2024 Annual RSUs, were awarded at $0.00 per unit and will vest concurrently with their underlying awards. This transaction represents routine equity compensation adjustments, increasing his total RSU holdings across these series.
Moelis & Co (MC) COO receives dividend-equivalent RSU awards tied to prior grants
Moelis & Company's Chief Operating Officer, Katherine Pilcher Ciafone, received dividend-equivalent Restricted Stock Unit (RSU) awards. These awards, totaling 39.150 2022 Incentive RSUs and 13.760 2021 Incentive RSUs, are linked to her unvested underlying RSUs from previous grants and will vest on the same schedule as the original awards. The awards can be settled in Class A common stock or cash equal to the fair market value of the share at settlement.
Moelis & Co (MC) counsel granted dividend equivalent RSUs tied to prior awards
Moelis & Co General Counsel and Secretary Osamu R. Watanabe received dividend equivalent Restricted Stock Units (RSUs) on June 18, 2026, tied to his unvested 2021-2025 Incentive RSUs and 2025 Special Incentive RSUs. These RSUs grant the right to receive either Moelis & Co Class A common stock or its cash equivalent and will vest concurrently with the underlying awards. This transaction is considered neutral in terms of filing impact and sentiment, as it pertains to equity-based compensation rather than open market purchases or sales.
Moelis & Co (MC) director receives 2025 dividend-equivalent RSU grant
Moelis & Co director Barker Thorold received a grant of 15.9600 2025 Annual Restricted Stock Units (RSUs) as dividend equivalents on existing underlying Annual RSUs. These RSUs, valued at $0.00 per share, will vest concurrently with the original Annual RSUs issued on July 14, 2025. Following this transaction, Thorold's direct holdings of Moelis & Co Class A equity total 1665.2500 shares/units.
Moelis (MC) Stock Could Be 2.2% Undervalued After Energy M And A Hire
Moelis & Company's stock (MC) is under scrutiny after the appointment of James McEwan, a Managing Director in the M&A energy sector. Despite recent positive share price momentum, the stock is considered slightly undervalued at $69.41 against a fair value estimate of $71.00, driven by expectations of faster revenue growth, stronger margins, and diversified revenue streams due to the company's global platform. However, concerns about high compensation costs, intense competition, and a high P/E ratio compared to peers suggest potential risks for investors.
How Moelis & Company Class A (MC) Affects Rotational Strategy Timing
This article provides an AI-generated analysis of Moelis & Company Class A (MC) stock, focusing on its impact on rotational strategy timing. It highlights neutral near-term sentiment with potential stalling of mid-term strong sentiment, noting an exceptional risk-reward short setup. The analysis includes various trading strategies—position, momentum breakout, and risk hedging—along with multi-timeframe signal analysis to inform traders.
How Moelis & Company Class A (MC) Affects Rotational Strategy Timing
Moelis & Company Class A (MC) shows a neutral near-term sentiment with a mid-channel oscillation pattern. AI models suggest specific trading strategies, including a position trading strategy targeting an upside, a momentum breakout strategy, and a risk-hedging short strategy. The analysis highlights an exceptional risk-reward short setup with a potential 10.8% downside.
Diluted shares outstanding of Moelis & Co. Class A – XETR:17M
This article focuses on the diluted shares outstanding of Moelis & Co. Class A, identified by its XETR:17M symbol on TradingView. It provides a financial overview, displaying the period, value, and percentage change for this metric. The content appears to be a data-driven snapshot from a financial platform.
Unusual income/expense of Moelis & Co. Class A – XETR:17M
This article focuses on the "Unusual income/expense" section for Moelis & Co. Class A, traded on XETRA under the ticker 17M. It provides a brief overview of the company's financial data on the TradingView platform. The content primarily lists market and data providers and various sections of the TradingView website.
ETFs Investing in Moelis & Co. Class A Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that invest in Moelis & Co. Class A stocks, sorted by market value. It details various ETFs, including their issuers, management styles, focus areas, expense ratios, assets under management (AUM), price changes, and 3-year NAV total returns. The information is designed to help investors identify suitable ETFs for investing in Moelis & Co. Class A stocks with potentially lower risk.
Moelis & Co. Class A Trade Ideas — XETR:17M
The article presents trade ideas for Moelis & Co. Class A (XETR:17M), focusing on its position as an advisory-focused investment bank and its potential to benefit from a recovery in Wall Street dealmaking, especially with the rise of the AI economy. It includes a specific Fibonacci analysis trading strategy and several mixed sentiment short-term trade ideas from various contributors. The content highlights Moelis's competition with other independent advisory firms and its higher-margin, less risky business model compared to universal banks.
Assessing Moelis (MC) Valuation After Recent Trading Moves And Perceived Undervaluation Gap
Moelis & Co. (MC) recently closed at US$65.76, showing a 5.6% gain over the past week but a 3.4% decline in the last month. Despite an estimated undervaluation gap of about 28% and a fair value of $76.50 according to one narrative, the stock's current P/E of 22.1x is higher than its estimated fair ratio of 14.9x, prompting questions about potential multiple compression. Investors are encouraged to weigh key rewards and warning signs and consider alternative investment opportunities.
Kayne Anderson Rudnick reports 5.78M Moelis shares (NASDAQ: MC) Amendment No.10
Kayne Anderson Rudnick Investment Management, LLC filed an Amendment No. 10 to Schedule 13G/A, disclosing beneficial ownership of 5,778,143 shares (7.9%) of Moelis & Co common stock. The filing details the firm's sole and shared voting and dispositive powers over these shares, and was signed on May 14, 2026. This disclosure indicates a large passive stake by Kayne Anderson Rudnick but does not signify an active change in strategy or transaction proceeds.
A Look At Moelis (MC) Valuation After Q1 Earnings, Buybacks, Dividend And New Shelf Registrations
Moelis & Company's recent Q1 earnings report, combined with buybacks, a maintained dividend, and new shelf registrations, presents a complex valuation picture. While the stock has seen an 11.15% return in the last 30 days, it is down 10.26% year-to-date. Simply Wall St's analysis suggests the stock is currently undervalued, with a fair value of $76.50 compared to its trading price of $63.91, driven by anticipated revenue growth, stronger margins, and improved earnings quality from recurring advisory assignments.
Moelis & Co ($MC) CEO 2025 Pay Revealed
Moelis & Co's CEO, Navid Mahmoodzadegan, is estimated to have received $42,846,376 in compensation for 2025, a significant increase from 2024. This information comes from a recent DEF14A SEC filing. The article also details recent insider trading activity, institutional holdings changes, analyst ratings, and price targets for MC stock.
Vanguard holds 3.88M Moelis & Co shares (MC) after Schedule 13G
Vanguard Capital Management has filed a Schedule 13G, disclosing beneficial ownership of 3,880,626 shares of Moelis & Co (MC), representing 5.28% of the class. The filing indicates that 565,586 of these shares are held with sole voting power, and the reported holdings include securities managed for various Vanguard funds and accounts. This disclosure clarifies Vanguard's status as a large passive holder, aligning with regulatory compliance requirements for holdings exceeding 5%.
X-Energy, Advanced Nuclear Reactor and Fuel Developer, Files for Nasdaq $1.02B IPO
X-Energy, a developer of advanced small modular nuclear reactors (SMRs) and nuclear fuels, has filed for a $1.02 billion initial public offering on Nasdaq under the ticker "XE." The company plans to offer over 44 million shares at $23.00 each, with proceeds primarily allocated to working capital, R&D, and capital expenditures. X-Energy's flagship Xe-100 reactor and TRISO-X fuel technology address an SMR market estimated to reach $2.3 trillion by 2050.
Moelis & Company (NYSE: MC) files S-3 shelf to sell Class A shares
Moelis & Company filed an S-3ASR shelf registration statement on April 30, 2026, to allow for the future sale of its Class A common stock by both the company and selling securityholders. The filing categorizes Moelis as a "well-known seasoned issuer," providing flexibility for delayed or continuous offerings. Proceeds from company sales will be used for general corporate purposes and contributed to Group LP, while no proceeds will be received by the company from securityholder resales.
Moelis (NYSE: MC) posts Q1 2026 revenue growth but lower EPS
Moelis & Company reported a 4% increase in Q1 2026 revenue, reaching $319.8 million, driven by higher average fees per completed transaction. Despite this growth, net income declined by 21% to $42.3 million ($0.51 basic EPS) primarily due to a tax expense in Q1 2026 compared to a significant tax benefit in Q1 2025. The company also announced a $0.65 per share dividend and authorized a new $300 million share repurchase program.
Moelis & Company (MC) Q1 2026 revenue rises 4% as it returns $171M
Moelis & Company reported first-quarter 2026 revenues of $319.8 million, a 4% increase year-over-year, driven by Private Capital Advisory and M&A activity. Despite an increase in revenue, GAAP net income and diluted EPS decreased by 21% and 25% respectively, primarily due to higher operating costs. The company maintained a strong balance sheet with $353.7 million in cash and no debt, and returned $171.4 million to shareholders through dividends and share repurchases, including a regular quarterly dividend of $0.65 per share.
